London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Responsibilities to the market regulator are the only reason why Marsden and Co provide an update.
A post on LinkedIn is NOT reporting to the market..
It was a poor response in the light of events. If you
do not have a Linked-In account you cannot read
anything posted on there! Synairgen have yet
again shown no respect for their PI's. They knew
about the presentation and should have informed us
exactly what results were being put forward, then
this whole debacle would have been avoided,
and those who were swept up in the mess would
not be nursing a loss! RM is not fit to be a CEO!
Mani - not sure if your post is directed to myself or someone?
The company have not provided any updates for a long time and that still remains the case.
Dick Marsden will only provide an update because the regulator tells him to publish full year results. He would be hiding in his cave otherwise.
The man who asked for £85m is now camera shy.
Look SNG only have ONE asset - its not like AZN that has an RNS every other day almost - so slowly slowly, newsflows; its our turn soon for something big....it works after all! SNG moves slowly but COULD be back v. soon. Happy weekend team
The attitude of the company is either
1) F U to the investors
Or
2) They genuinely believe they are doing everything the correct way.
Both options are incredibly worrying. There is no middle ground it is either 1 or 2.
A third and more plausible reason imo is because they are not at liberty to say, yet.
New CMO, new CFO, new staff all joining same month -> That isn't a coincidence.
Fruits, that's seven months ago, so what's your interpretation?
Like I said, it looks most likely to me that they are not at liberty to say, yet. Blanket silence smells of something in the works. I can't see Mankowski or Colliver choosing to join a sinking ship, not from where they came and the opportunities they left behind to take on their new respective SNG roles. But obvs DYOR, which I'm sure you will.
Reputation risk is very low. They could easily go for the call option. Rich and famous if succesfull because of all the free options.
If it doesnt work out they received a good income and off to the next option
?
It's just perplexing though isn't it. Brysoa brings the news of the conference - and we start to feel a little happier. The next day pmjh posts Amanda Horton's tweet which shows the specifics of the poster presentation and we're even happier - hell Professional even apologises to the company. And the sp climbs dramatically, even if part of that rise was down to market-maker shenanigans. Then it's Thursday, the tweet is deleted - Synairgen makes a pitiful Linkedin post, seen by nobody, which instead of showing the data slide revealed the day before takes the reader to the Conference's homepage and then on to the preview paragraph we'd seen 2 days before and nothing substantive, and the ar.se falls out of the sp again. . I guess there are reasons for the nonsense - I guess we can still celebrate the fact that UKHSA has collaborated ( for as Brand says, they are in no sense a commercial lab ) on a new set of ivs - and we can still surmise on the interesting possibilities this may throw up. But the deleted UKHSA tweet makes no sense. It can't be a secret squirrel exercise. The board was up for all the world to see and snap for at least 2 days.Any tom dick or harry could have photographed it and posted it.
And we're left with Synairgen's hamfisted comms team managing yet again to turn a small but genuine nugget into pyrite. Our first tiny sniff of salvation after so long waiting and they've screwed it up.
Fruits - ok so that explains the last 6 months of keeping quiet, what about the previous 18 months of BS?!
You sound needy this evening Costas.
So you can't explain the previous 18 months. That's fine, I don't need anything else.
Hopefully the results RNS is only a couple of weeks away,
then RM has to come out of hiding to give us an update
and confirm our financial status.... It needs to be a comprehensive
outline of exactly where we are, nothing less !
Expect - ‘ nothing less ‘
Just to check
are we very certain UKHSA have collaborated on a new set of ivs?
I haven't been able to read the abstracts....been out looking at trees and little dogs all day but if someone is certain on this please tell me where to look or just confirm that yes indeed we have a new set of ivs.
Xv it's definitely new work. Funded by Synairgen and conducted by UKHSA at Porton Down
UKHSA. The Antiviral efficacy of IFN-B1a ( SNG001) against different SARS-CoV-2 variants, in vitro.
Amanda Horton, Sarah A Dudley, Matthew Wand, Daniel Packham, Irebe CanoCeja, Victoria J. Tear, Philip D,Monk J.Mark Sutton, Julia A.Tree ( 6 UKHSA 3 x Synairgen)
"In this study we tested the antiviral efficacy of SNG001, in vitro, against a variety of SARS-CoV-2 variants to provide reassurance that IFN-B1a was effective against the different variants as they emerged.
Thank you.
Well that does indeed change or shift the picture here. Glad I added some stock as soon as I read Brysoa's post. Have a good week all.
I guess there's a good chance they are gearing up for a roll of the dice.
And as Mani has been signaling the £ situation might need a little bump. Hopefully nothing 2 drastic.
And onwards they lurch, hopefully.
We should at least get an RNS this week with notice of full years results.
It’s all been positive and my owns thoughts is that they will share some major news on this share. It’s not dead in the water but seems to now have a brighter future. Ok we need some further testing but it’s all in the right direction. It’s still worth a punt. I keep slowly adding.
Have a good day folks !
Results are normally on a Thursday, so we would have had
a RNS today to give the 10 days notice if they are out this month..
Looks like they will be later this year !
Feeling Lucky....Just rebought 100k shares @ 6.6 after selling at 9.6
Rinse repeat? Lets go Marsden ;)
Pro
I think you are pulling a fast one...
The 100K trade is a UT... Naughty step for you!!! :D